home / stock / vm:cc / vm:cc news

VM:CC News and Press, Voyageur Pharmaceuticals Ltd.

Stock Information
Company Name: Voyageur Pharmaceuticals Ltd.
Stock Symbol: VM:CC
Market: TSXVC
Website: voyageurpharmaceuticals.ca
Menu
VM:CC VM:CC Quote VM:CC Short VM:CC News VM:CC Articles VM:CC Message Board
Get VM:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
VM:CC - Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt

(TheNewswire) Purity Exceeding Pharmaceutical Grade, 98.8% BaSO4   Moving on to Stage 2 of the Alberta Innovates AICE-Market Access Program     Calgary, Alberta, Canada – March 4, 2026 – TheNewswire – Voyageur Pharmaceutica...
VM:CC - Voyageur Pharmaceuticals Announces Collaboration with Bayer

(TheNewswire)    Calgary, Alberta, Canada – TheNewswire – February 23, 2026 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM ) ( OTC Pink:VYYRF) (" Voyageur " or the " Company ") a Canadian developer of pharmaceutical-grade barium and iodine for medical imaging...

VM:CC - Voyageur Pharmaceuticals Strengthens Scientific Team by Adding Dr. Brian Mueller as Director of Chemistry and Secures Exclusive Ownership of Iodine Extraction Technology

(TheNewswire) Calgary, Alberta, Canada – TheNewswire - January 12, 2026 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company"), a Canadian developer of pharmaceutical-grade barium and iodine for medical imaging contrast media, is excited to announc...

VM:CC - Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion

(TheNewswire) Calgary, AB – November 7, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC: VYYRF) (the “Company” or “Voyageur”), a Canadian developer of pharmaceutical-grade barium and iodine for medical imaging contrast...
VM:CC - Voyageur Pharmaceuticals Signs Non-Exclusive Distribution & Wholesale Agreement with PHALANX

(TheNewswire) Calgary, Alberta, Canada – October 29, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”), a Canadian public company developing cost-effective imaging contrast media...

VM:CC - Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Wall Street Expertise to Facilitate U.S. Market Expansion

(TheNewswire) Calgary, AB – October 23, 2025 - TheNewswire – Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC: VYYRF), (the “Company” or “Voyageur”) a Canadian developer of pharmaceutical-grade barium and iodine for medical imaging cont...

VM:CC - Voyageur Pharmaceuticals Launches U.S. Iodine Feasibility Study to Establish First Fully Integrated North American Contrast Drug Manufacturing Platform

(TheNewswire) Calgary, Canada – TheNewswire – August 25, 2025 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) ("Voyageur" or the "Corporation") is pleased to announce the launch of its U.S.-based iodine feasibility program, a major step toward establishing a verticall...
VM:CC - Voyageur Pharmaceuticals Grants Deferred Share Units and Options and Accelerates Expiry Date of Warrants

(TheNewswire) Calgary, Canada – TheNewswire – July 14, 2025 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) ("Voyageur" or the "Corporation"), a provider of innovative medical imaging solutions, announces that it has issued 128,418 Deferred Share Units ("DSUs"...

VM:CC - Voyageur Pharmaceuticals Signs LOI for Latin America Distribution Partnership Supporting Global Market Expansion

(TheNewswire) Calgary, Alberta, Canada – TheNewswire - June 24, 2025 – Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“ Voyageur ”, or the “ Company ”), a Canadian public company developing cost-effective imag...

VM:CC - Voyageur and Altillion Forge Landmark Alliance to Establish North America's First Vertically Integrated Iodine Drug Supply Chain

(TheNewswire) Calgary, Alberta – TheNewswire - June 23, 2025 – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (“Voyageur” or the “Company”), a Canadian public company developing cost-effective imaging contrast media, is pleased to annou...
Next 10